The Haloperidol Injection, cataloged under National Stock Number 6505-01-683-6307, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-683-6307 |
| Primary Part Number | NDC25021-0806-01 |
| Item Name | Haloperidol Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 5.0 MILLIGRAMS OR 1.0 MILLILITERS |
| Secondary Container Type | VIAL |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC25021-0806-01 | Cardinal Health 200, Llc (USA) |
| NDC25021-0806-01 PRIMARY | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM195647 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1557217 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-683-6307 is a Haloperidol Injection, manufactured by Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-683-6307 has 2 manufacturer part numbers on file: NDC25021-0806-01 (Cardinal Health 200, Llc), NDC25021-0806-01 (Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc).
Key specifications for NDC25021-0806-01: Primary Container Content Quantity: 5.0 MILLIGRAMS OR 1.0 MILLILITERS; Secondary Container Type: VIAL; Special Features: HALOPERIDOL INJECTION, USP; 5 MG/ML VIAL, 10 VIALS PER PACKAGE. STERILE, NONPYROGENIC. THE CONTAINER CLOSURE IS NOT MADE WITH NATURAL RUBBER LATEX.S TORE AT 20 TO 25 C (68 TO 77 F). SEE USP CONTROLLED ROOM TEMPERATURE. DO NOT FREEZE. PROTECT FROM LIGHT. RETAIN IN CARTON UNTIL TIME OF USE.; Part Name Assigned by Controlling Agency: HALOPERIDOL LACTATE 5 MG/ML VIAL, 10S. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.